<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK379665" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK379665/" /><meta name="ncbi_pagename" content="SCN8A-Related Epilepsy with Encephalopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SCN8A-Related Epilepsy with Encephalopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SCN8A-Related Epilepsy with Encephalopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/08/25" /><meta name="citation_author" content="Michael F Hammer" /><meta name="citation_author" content="Jacy L Wagnon" /><meta name="citation_author" content="Heather C Mefford" /><meta name="citation_author" content="Miriam H Meisler" /><meta name="citation_pmid" content="27559564" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK379665/" /><meta name="citation_keywords" content="Early-Infantile Epileptic Encephalopathy 13 (EIEE13)" /><meta name="citation_keywords" content="Early Infantile Epileptic Encephalopathy 13 (EIEE13)" /><meta name="citation_keywords" content="Sodium channel protein type 8 subunit alpha" /><meta name="citation_keywords" content="SCN8A" /><meta name="citation_keywords" content="SCN8A-Related Epilepsy with Encephalopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SCN8A-Related Epilepsy with Encephalopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Michael F Hammer" /><meta name="DC.Contributor" content="Jacy L Wagnon" /><meta name="DC.Contributor" content="Heather C Mefford" /><meta name="DC.Contributor" content="Miriam H Meisler" /><meta name="DC.Date" content="2016/08/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK379665/" /><meta name="description" content="SCN8A-related epilepsy with encephalopathy is characterized by developmental delay, seizure onset in the first 18 months of life (mean 4 months), and intractable epilepsy characterized by multiple seizure types (generalized tonic-clonic seizures, infantile spasms, and absence and focal seizures). Epilepsy syndromes can include Lennox-Gastaut syndrome, West syndrome, and epileptic encephalopathies (e.g., Dravet syndrome). Hypotonia and movement disorders including dystonia, ataxia, and choreoathetosis are common. Psychomotor development varies from normal prior to seizure onset (with subsequent slowing or regression after seizure onset) to abnormal from birth. Intellectual disability, present in all, ranges from mild to severe (in ~50% of affected individuals). Autistic features are noted in some. Sudden unexpected death in epilepsy (SUDEP) of unknown cause has been reported in approximately 10% of published cases. To date SCN8A-related epilepsy with encephalopathy has been reported in the literature in about 50 individuals." /><meta name="og:title" content="SCN8A-Related Epilepsy with Encephalopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="SCN8A-related epilepsy with encephalopathy is characterized by developmental delay, seizure onset in the first 18 months of life (mean 4 months), and intractable epilepsy characterized by multiple seizure types (generalized tonic-clonic seizures, infantile spasms, and absence and focal seizures). Epilepsy syndromes can include Lennox-Gastaut syndrome, West syndrome, and epileptic encephalopathies (e.g., Dravet syndrome). Hypotonia and movement disorders including dystonia, ataxia, and choreoathetosis are common. Psychomotor development varies from normal prior to seizure onset (with subsequent slowing or regression after seizure onset) to abnormal from birth. Intellectual disability, present in all, ranges from mild to severe (in ~50% of affected individuals). Autistic features are noted in some. Sudden unexpected death in epilepsy (SUDEP) of unknown cause has been reported in approximately 10% of published cases. To date SCN8A-related epilepsy with encephalopathy has been reported in the literature in about 50 individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK379665/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/scn8a-ee/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK379665/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A2B8CE040763100000000061F0231.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK379665_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK379665_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gefs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/etha/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK379665_"><span class="title" itemprop="name"><i>SCN8A</i>-Related Epilepsy with Encephalopathy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Early-Infantile Epileptic Encephalopathy 13 (EIEE13)</div><p class="contrib-group"><span itemprop="author">Michael F Hammer</span>, PhD, <span itemprop="author">Jacy L Wagnon</span>, PhD, <span itemprop="author">Heather C Mefford</span>, MD, PhD, and <span itemprop="author">Miriam H Meisler</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK379665_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK379665_ai__"><div class="contrib half_rhythm"><span itemprop="author">Michael F Hammer</span>, PhD<div class="affiliation small">Professor of Neurology<br />Arizona Research Laboratories Division of Biotechnology<br />University of Arizona<br />Tucson, Arizona<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.anozira.liame@hfm" class="oemail">ude.anozira.liame@hfm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jacy L Wagnon</span>, PhD<div class="affiliation small">Research Investigator in Human Genetics<br />University of Michigan<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu@nongawj" class="oemail">ude.hcimu@nongawj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Heather C Mefford</span>, MD, PhD<div class="affiliation small">Associate Professor, Pediatrics<br />University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="de.wu@droffemh" class="oemail">de.wu@droffemh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Miriam H Meisler</span>, PhD<div class="affiliation small">Professor of Human Genetics<br />University of Michigan<br />Ann Arbor, Michigan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hcimu@mrelsiem" class="oemail">ude.hcimu@mrelsiem</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 25, 2016</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="scn8a-ee.Summary" itemprop="description"><h2 id="_scn8a-ee_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SCN8A</i>-related epilepsy with encephalopathy is characterized by developmental delay, seizure onset in the first 18 months of life (mean 4 months), and intractable epilepsy characterized by multiple seizure types (generalized tonic-clonic seizures, infantile spasms, and absence and focal seizures). Epilepsy syndromes can include Lennox-Gastaut syndrome, West syndrome, and epileptic encephalopathies (e.g., Dravet syndrome). Hypotonia and movement disorders including dystonia, ataxia, and choreoathetosis are common. Psychomotor development varies from normal prior to seizure onset (with subsequent slowing or regression after seizure onset) to abnormal from birth. Intellectual disability, present in all, ranges from mild to severe (in ~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals). Autistic features are noted in some. Sudden unexpected death in epilepsy (SUDEP) of unknown cause has been reported in approximately 10% of published cases. To date <i>SCN8A</i>-related epilepsy with encephalopathy has been reported in the literature in about 50 individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with encephalopathy and epilepsy and identification of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SCN8A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Seizure control should be managed by a pediatric neurologist with expertise in epilepsy management who is familiar with the pharmacotherapy for <i>SCN8A</i>-related epilepsy with encephalopathy and aware of how it differs from treatment of similar disorders. Vigorous attempts to control seizures are warranted. Several studies suggest a favorable response to sodium channel blockers.</p><p><i>Surveillance:</i> Periodic evaluation for neurologic, cognitive, and/or behavioral deterioration; monitoring with EEG and other modalities such as video EEG telemetry or ambulatory EEG when new or different seizure types are suspected. Because of the increased risk of SUDEP, some families use oxygen monitoring during sleep.</p><p><i>Agents/circumstances to avoid:</i> Several families of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals report worsening of seizures with levetiracetam.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SCN8A</i>-related epilepsy with encephalopathy is expressed in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and typically do not reproduce. While the risk to future pregnancies is presumed to be low, some parents of an affected child may wish to consider prenatal testing or <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> in future pregnancies as the risk may be slightly greater than in the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</p></div></div><div id="scn8a-ee.Diagnosis"><h2 id="_scn8a-ee_Diagnosis_">Diagnosis</h2><div id="scn8a-ee.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SCN8A</i>-related epilepsy with encephalopathy <b>should be suspected</b> in individuals with early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with ongoing epileptiform activity), particularly those with the following epilepsy features, seizure types, and/or epilepsy syndromes.</p><p><b>Epilepsy features</b></p><ul><li class="half_rhythm"><div>Seizure onset in the first 18 months of life (mean age 4 months)</div></li><li class="half_rhythm"><div>Focal clonic seizures evolving into bilateral convulsive seizures</div></li><li class="half_rhythm"><div>Development of multiple seizure types</div></li><li class="half_rhythm"><div>Motor abnormalities including hypotonia</div></li><li class="half_rhythm"><div>Movement disorders including dystonia, ataxia, choreoathetosis</div></li></ul><p><b>Seizure types</b></p><ul><li class="half_rhythm"><div>Intractable childhood epilepsy with generalized tonic-clonic seizures</div></li><li class="half_rhythm"><div>Infantile spasms</div></li><li class="half_rhythm"><div>Absence and focal seizures</div></li></ul><p><b>Epilepsy syndromes</b></p><ul><li class="half_rhythm"><div>Lennox-Gastaut syndrome</div></li><li class="half_rhythm"><div>West syndrome</div></li><li class="half_rhythm"><div>Early-onset epilepsy with hypotonia, movement disorders, and/or intellectual disability (e.g., Dravet syndrome)</div></li></ul></div><div id="scn8a-ee.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SCN8A</i>-related epilepsy with encephalopathy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with encephalopathy and epilepsy by identification of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SCN8A</i> through <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK379665/table/scn8a-ee.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figscn8aeeTmoleculargenetictestinguse" rid-ob="figobscn8aeeTmoleculargenetictestinguse">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>targeted <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing).</p><p>Targeted <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing requires the clinician to develop a hypothesis about which specific gene(s) are likely to be involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Because the phenotypes of many genetic epileptic encephalopathies overlap, most children with <i>SCN8A</i> encephalopathy with epilepsy are diagnosed by following <a href="#scn8a-ee.Recommended_Testing">recommended testing</a> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or <a href="#scn8a-ee.Testing_to_Consider">testing to consider</a> (comprehensive genomic sequencing). Note that testing of <i>SCN8A</i> alone (i.e., single-gene testing) is rarely used.</p><div id="scn8a-ee.Recommended_Testing"><h4>Recommended Testing</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that</b> includes <i>SCN8A</i> and other genes of interest (see <a href="#scn8a-ee.Differential_Diagnosis">Differential Diagnosis</a>) is the recommmmended approach. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="scn8a-ee.Testing_to_Consider"><h4>Testing to Consider</h4><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from other inherited disorders (or the phenotype alone is insufficient to support focused <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="scn8a-ee.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SCN8A</i>-Related Encephalopathy with Epilepsy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK379665/table/scn8a-ee.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scn8a-ee.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN8A</i></td><td headers="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_scn8a-ee.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported to date&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="scn8a-ee.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/scn8a/#scn8a.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="scn8a-ee.TF.1.2"><p class="no_margin">See <a href="#scn8a-ee.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="scn8a-ee.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="scn8a-ee.TF.1.4"><p class="no_margin">In the first 100 individuals with <i>SCN8A</i>-related encephalopathy with epilepsy, all <i>SCN8A</i> pathogenic variants were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants with the exception of one <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant predicted to cause an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#scn8a-ee.REF.rauch.2012.1674">Rauch et al 2012</a>; <a class="bk_pop" href="#scn8a-ee.REF.veeramah.2012.502">Veeramah et al 2012</a>; <a class="bk_pop" href="#scn8a-ee.REF.carvill.2013.825">Carvill et al 2013</a>; <a class="bk_pop" href="#scn8a-ee.REF.allen.2013.217">Allen et al 2013</a>; <a class="bk_pop" href="#scn8a-ee.REF.de_kovel.2014.1511">de Kovel et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.estacion.2014.117">Estacion et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.ohba.2014.994">Ohba et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.vaher.2014.np202">Vaher et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.blanchard.2015.330">Blanchard et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.dyment.2015.34">Dyment et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.fung.2015.1319">Fung et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.kong.2015a.431">Kong et al 2015a</a>; <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.mercimekmahmutoglu.2015.707">Mercimek-Mahmutoglu et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.olson.2015.2017">Olson et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.takahashi.2015.758">Takahashi et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015a.114">Wagnon et al 2015a</a>; <a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>; M Hammer, unpublished data].</p></div></dd><dt>5. </dt><dd><div id="scn8a-ee.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="scn8a-ee.Clinical_Characteristics"><h2 id="_scn8a-ee_Clinical_Characteristics_">Clinical Characteristics</h2><div id="scn8a-ee.Clinical_Description"><h3>Clinical Description</h3><p><i>SCN8A</i> pathogenic variants have been associated with developmental delay prior to and/or after onset of seizures, intellectual disability without seizures, and epileptic encephalopathy.</p><p><i>SCN8A</i>-related epilepsy with encephalopathy is an early-onset, intractable epilepsy characterized by multiple seizure types and developmental delay. To date 50 individuals with a d<i>e novo SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported [<a class="bk_pop" href="#scn8a-ee.REF.rauch.2012.1674">Rauch et al 2012</a>, <a class="bk_pop" href="#scn8a-ee.REF.veeramah.2012.502">Veeramah et al 2012</a>, <a class="bk_pop" href="#scn8a-ee.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#scn8a-ee.REF.carvill.2013.825">Carvill et al 2013</a>, <a class="bk_pop" href="#scn8a-ee.REF.de_kovel.2014.1511">de Kovel et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.estacion.2014.117">Estacion et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.ohba.2014.994">Ohba et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.vaher.2014.np202">Vaher et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.blanchard.2015.330">Blanchard et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.dyment.2015.34">Dyment et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.fung.2015.1319">Fung et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.kong.2015a.431">Kong et al 2015a</a>, <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.mercimekmahmutoglu.2015.707">Mercimek-Mahmutoglu et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.olson.2015.2017">Olson et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.takahashi.2015.758">Takahashi et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015a.114">Wagnon et al 2015a</a>, <a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>].</p><p>The most common clinical features of <i>SCN8A</i>-related epilepsy with encephalopathy are described below. Of note, sudden setbacks of unknown cause are common.</p><p><b>Seizures</b>. In 48 of the 50 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date age of onset of seizures ranged from the first day of life to age 22 months (median age: 4 months; mean age: 4.7 months). Of note, prenatal onset of seizures may occur as some mothers reported unusual "drumming" movements in the later stages of pregnancy [<a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>].</p><p>Initial seizure type varies, and most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop additional seizure types, including the following:</p><ul><li class="half_rhythm"><div>Focal clonic seizures evolving to a bilateral convulsive seizure</div></li><li class="half_rhythm"><div>Afebrile generalized tonic clonic seizures</div></li><li class="half_rhythm"><div>Tonic seizures</div></li><li class="half_rhythm"><div>Infantile spasms</div></li><li class="half_rhythm"><div>Myoclonic seizures</div></li></ul><p>Although both convulsive and non-convulsive status epilepticus appear to be common [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>], they are not as common as in Dravet syndrome.</p><p>Seizure frequencies range from hundreds per day to fewer than one per month.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have refractory seizures and require polytherapy (see <a href="#scn8a-ee.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p><p><b>Psychomotor development</b> varies from normal prior to seizure onset (with subsequent slowing or regression after seizure onset) to abnormal from birth [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>]. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals experience marked slowing or arrest in development either for no apparent reason or after an event that occurred before the developmental decline, such as a change in seizure type or change in medication.</p><p>Approximately half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children learn to sit and walk unassisted; the remainder are non-ambulatory. Ataxia and sudden loss of mobility are common in those who are ambulatory.</p><p>The oldest patient of whom the authors are aware is 47 years old; the majority of diagnosed individuals are younger than age 20 years. For the several who are in their teens, cognitive and motor disabilities persist.</p><p>Language is frequently affected. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals speak few or no words.</p><p><b>Intellectual disability</b> ranges from mild to severe, with about half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals having severe intellectual disability. Autistic features are noted in some [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>].</p><p><b>Movement abnormalities</b> including hypotonia, dystonia, choreoathetosis, ataxia, spasticity, and increased startle have been described in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Startle and sleep problems.</b> Many children are hyper-alert as infants (i.e., more awake and aware of their surroundings than typical infants) and are easily startled. For example, <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al [2015]</a> reported a newborn with jittery movements shortly after birth and a pathologically exaggerated startle response to tactile and acoustic stimuli, findings that prompted a suspicion of <a href="/books/n/gene/hyperek/">hyperekplexia</a>. The hyper-alert sleep appears to make it difficult for the infant to settle into a deep, healthy sleep. These findings have been anecdotally reported in several other individuals with <i>SCN8A</i>-related encephalopathy with epilepsy.</p><p><b>Associated medical problems</b>, reported in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, can include the following:</p><ul><li class="half_rhythm"><div>Autonomic nervous system dysfunction, including difficulty with temperature regulation and tachypnea</div></li><li class="half_rhythm"><div>Hearing problems</div></li><li class="half_rhythm"><div>Bone fractures, often associated with prolonged seizures</div></li><li class="half_rhythm"><div>Laryngomalacia</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Cortical visual impairment</div></li><li class="half_rhythm"><div>Gum hyperplasia secondary to antiepileptic drugs (AEDs)</div></li></ul><p><b>Sudden unexpected death in epilepsy (SUDEP)</b> has been reported in approximately 10% of published cases [<a class="bk_pop" href="#scn8a-ee.REF.veeramah.2012.502">Veeramah et al 2012</a>, <a class="bk_pop" href="#scn8a-ee.REF.estacion.2014.117">Estacion et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.kong.2015a.431">Kong et al 2015a</a>, <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>]. The cause of SUDEP is unknown, but may be related to prolonged seizures, cardiac abnormalities, or brain stem dysfunction. SUDEP can occur at any age.</p><p><b>EEG.</b> Early on the EEG may be normal or exhibit focal or multifocal epileptiform activity. The EEG tends to evolve over time, often showing moderate to severe background slowing and focal or multifocal sharp waves or spikes, most often in the temporal regions. Some show almost continuous delta slowing in the temporo-parietal-occipital regions, with superimposed beta frequencies and bilateral asynchronous spikes or sharp waves [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>].</p><p><b>Brain MRI</b> is usually normal at the onset of seizures; however, abnormal findings may include cerebral atrophy and hypoplasia of the corpus callosum. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been shown to have developed cerebral or cerebellar atrophy in follow-up studies [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>].</p></div><div id="scn8a-ee.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>There is no obvious correlation between the position of an <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the seizure onset, seizure type, or clinical severity. Most pathogenic variants are located in the transmembrane segments of the channel.</p><p>Notable similarities in age of onset and movement impairment were reported in two severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, unrelated individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK379665/table/scn8a-ee.T.scn8a_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figscn8aeeTscn8avariantsdiscussedint" rid-ob="figobscn8aeeTscn8avariantsdiscussedint">p.Ile1327Val</a> [<a class="bk_pop" href="#scn8a-ee.REF.vaher.2014.np202">Vaher et al 2014</a>, <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>]; in contrast, however, multiple individuals with the pathogenic variant <a class="figpopup" href="/books/NBK379665/table/scn8a-ee.T.scn8a_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figscn8aeeTscn8avariantsdiscussedint" rid-ob="figobscn8aeeTscn8avariantsdiscussedint">p.Arg1617Gln</a> had different ages of onset and disease severity [<a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015.104">Wagnon &#x00026; Meisler 2015</a>].</p></div><div id="scn8a-ee.Penetrance"><h3>Penetrance</h3><p>Penetrance for <i>SCN8A</i>-related epilepsy with encephalopathy is unknown but assumed to be complete.</p><ul><li class="half_rhythm"><div>All <i>SCN8A</i> pathogenic variants identified to date have been <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or inherited from a parent with a somatic mosaic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that included the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</div></li><li class="half_rhythm"><div>None of the <i>SCN8A</i> pathogenic variants have been seen in unaffected individuals, including controls in various studies and the ExAC database of ~60,000 genomes (<a href="http://exac.broadinstitute.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">exac.broadinstitute.org</a>).</div></li></ul></div><div id="scn8a-ee.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>SCN8A</i>-related epilepsy with encephalopathy is not known.</p><p>The frequency of <i>SCN8A</i> pathogenic variants among individuals with epileptic encephalopathy was 13/1557 (close to 1%) in four independent studies, each of which included several hundred individuals [<a class="bk_pop" href="#scn8a-ee.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#scn8a-ee.REF.carvill.2013.825">Carvill et al 2013</a>, <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.mercimekmahmutoglu.2015.707">Mercimek-Mahmutoglu et al 2015</a>].</p></div></div><div id="scn8a-ee.Genetically_Related_Allelic_Dis"><h2 id="_scn8a-ee_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with mutation of <i>SCN8A</i>.</p><p>See <a href="#scn8a-ee.Molecular_Genetics">Molecular Genetics</a>, <b>Variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a></b> for discussion of phenotypes observed in individuals with these types of variants.</p></div><div id="scn8a-ee.Differential_Diagnosis"><h2 id="_scn8a-ee_Differential_Diagnosis_">Differential Diagnosis</h2><p>The clinical features associated with a <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> overlap significantly with other genetic (and non-genetic) epileptic encephalopathies. The differential diagnosis should include all genes known to be associated with early infantile epileptic encephalopathy (&#x0003e;30 have been identified; see <a href="http://omim.org/phenotypicSeries/PS308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM Phenotypic Series</a>).</p><p>Structural abnormalities of the brain that cause epileptic encephalopathy should be included in the differential diagnosis and can be identified by brain MRI.</p><p>Treatable neurometabolic disorders causing early infantile-onset epileptic encephalopathy that should be considered in the differential diagnosis include:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/pds/">Pyridoxine-dependent epilepsy</a></div></li><li class="half_rhythm"><div>Pyridoxamine 5'-phosphate oxidase deficiency (OMIM <a href="http://omim.org/entry/610090" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610090</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/biotin/">Biotinidase deficiency</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/glut1/">Glucose transporter 1 deficiency syndrome</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/creatine/">Creatine deficiency syndromes</a></div></li><li class="half_rhythm"><div>Holocarboxylase synthetase deficiency (OMIM <a href="http://omim.org/entry/253270" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253270</a>)</div></li><li class="half_rhythm"><div>Serine biosynthesis disorders including:</div><ul><li class="half_rhythm"><div>Phosphoglycerate dehydrogenase deficiency (OMIM <a href="http://omim.org/entry/601815" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">601815</a>)</div></li><li class="half_rhythm"><div>Phosphoserine aminotransferase deficiency (OMIM <a href="http://omim.org/entry/610992" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610992</a>)</div></li><li class="half_rhythm"><div>Phosphoserine phosphate deficiency (OMIM <a href="http://omim.org/entry/614023" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614023</a>)</div></li></ul></li></ul><p><a href="/books/n/gene/gefs/"><b>Dravet syndrome</b></a> is an infantile epileptic encephalopathy characterized by hemiclonic or generalized seizures that are often triggered by fever. More than 80% of individuals with Dravet syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SCN1A</i> (a related sodium channel <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) that results in loss of function due to protein truncation (60%) or pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that inactivate the channel [<a class="bk_pop" href="#scn8a-ee.REF.marini.2011.24">Marini et al 2011</a>]. The distinction between epilepsy caused by mutation of <i>SCN1A</i> and epilepsy caused by mutation of <i>SCN8A</i> is important because sodium channel blockers should be avoided in Dravet syndrome whereas they may be beneficial in <i>SCN8A</i>-related epilepsy with encephalopathy (see <a href="#scn8a-ee.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p><p>Distinctions between <i>SCN8A</i>-related epilepsy with encephalopathy and Dravet syndrome include:</p><ul><li class="half_rhythm"><div><b>Age of onset.</b> The mean age of onset is similar but the range of 0 days to 22 months in <i>SCN8A</i>-related epilepsy with encephalopathy is broader than that seen in Dravet syndrome.</div></li><li class="half_rhythm"><div><b>Febrile seizures.</b> Susceptibility to seizures with fever is common in Dravet syndrome, but rare in <i>SCN8A</i>-related encephalopathy with epilepsy.</div></li><li class="half_rhythm"><div><b>Infantile spasms.</b> Many patients with <i>SCN8A</i>-related epilepsy with encephalopathy present with spasms, which are not a feature of Dravet syndrome.</div></li><li class="half_rhythm"><div><b>Myoclonic seizures.</b> Patients with <i>SCN8A</i>-related epilepsy with encephalopathy rarely have myoclonic seizures, which are common in Dravet syndrome.</div></li><li class="half_rhythm"><div><b>Hypotonia and movement disorders</b> are common in patients with <i>SCN8A</i>-related encephalopathy with epilepsy, but are not typical of Dravet syndrome.</div></li><li class="half_rhythm"><div><b>EEG findings.</b> Generalized spike wave, a hallmark of Dravet syndrome after age one to two years, is not typical in <i>SCN8A</i>-related encephalopathy with epilepsy.</div></li><li class="half_rhythm"><div><b>Medications.</b> Sodium channel blockers such as carbamazepine, oxcarbazepine, and phenytoin appear to be the most efficacious antiepileptic drug (AED) for <i>SCN8A</i>-related epilepsy with encephalopathy [<a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>], while many patients with Dravet syndrome do worse on sodium channel blockers.</div></li></ul></div><div id="scn8a-ee.Management"><h2 id="_scn8a-ee_Management_">Management</h2><div id="scn8a-ee.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>SCN8A</i>-related encephalopathy with epilepsy, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination including:</div><ul><li class="half_rhythm"><div>EEG, which may provide an assessment of the overall degree of epileptic encephalopathy and seizure type</div></li><li class="half_rhythm"><div>Brain MRI if not previously performed</div></li></ul></li><li class="half_rhythm"><div>Cognitive and behavioral neuropsychological evaluation</div></li><li class="half_rhythm"><div>ECG to assess for cardiac arrhythmias, which have been identified in some patients with mutation of genes encoding other sodium channel subunits and may increase the risk of sudden unexpected death in epilepsy (SUDEP)</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="scn8a-ee.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No published treatment guidelines exist.</p><p><b>Seizure control</b> should be managed by a pediatric neurologist with expertise in epilepsy management who is familiar with the pharmacotherapy for <i>SCN8A</i>-related epilepsy with encephalopathy and how it differs from treatment of similar disorders (e.g., Dravet syndrome; see <a href="/books/n/gene/gefs/"><i>SCN1A</i>-Related Seizure Disorders</a> and <a href="#scn8a-ee.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>Vigorous attempts to control seizures with drug polytherapy are warranted because children with <i>SCN8A</i>-related epilepsy with encephalopathy are at risk for sudden unexplained death in epilepsy (SUDEP) as well as prolonged acute seizures that may cause permanent injury [<a class="bk_pop" href="#scn8a-ee.REF.chipaux.2010.190">Chipaux et al 2010</a>, <a class="bk_pop" href="#scn8a-ee.REF.takayanagi.2010.1886">Takayanagi et al 2010</a>].</p><p><b>Sodium channel blockers.</b> Several studies suggest that patients with <i>SCN8A</i>-related epilepsy with encephalopathy respond favorably to the class of antiepileptic drugs (AEDs) that block sodium channels; these include phenytoin, valproate, carbamazepine, lacosamide, lamotrigine, rufinamide, and oxcarbazepine [<a class="bk_pop" href="#scn8a-ee.REF.kong.2015b.1320">Kong et al 2015b</a>, <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>]. The effectiveness of sodium channel blockers is consistent with the activating effects of most <i>SCN8A</i> pathogenic variants [<a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015.104">Wagnon &#x00026; Meisler 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015a.114">Wagnon et al 2015a</a>, <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015b.506">Wagnon et al 2015b</a>]. Most patients are maintained on multiple medications with incomplete seizure control. One study of four patients reported a positive response to high doses of phenytoin [<a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>].</p><p><b>Other AEDs</b></p><ul><li class="half_rhythm"><div><b>Clobazam</b>, part of the standard of care for epilepsy in Europe, is now FDA-approved for the treatment of seizures in Lennox-Gastaut syndrome [<a class="bk_pop" href="#scn8a-ee.REF.selmer.2009.555">Selmer et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Phenobarbital,</b> while effective for seizure control, is poorly tolerated because of its effects on cognition.</div></li><li class="half_rhythm"><div><b>Levetiracetam</b> (Keppra<sup>&#x000ae;</sup>) has been reported by several families to be ineffective or occasionally associated with an increase in seizure frequency [M Hammer, unpublished data].</div></li></ul><p><b>Other.</b> When seizures are not responsive to conventional AEDs, the following drugs/treatment modalities may be effective based on anecdotal information:</p><ul><li class="half_rhythm"><div>Corticosteroids</div></li><li class="half_rhythm"><div>Immunoglobulins</div></li><li class="half_rhythm"><div>Vagus nerve stimulator</div></li><li class="half_rhythm"><div>Ketogenic diet</div></li><li class="half_rhythm"><div>Cannabinoids</div></li></ul><p><b>Sleep hygiene.</b> As described for Dravet syndrome, sleep deprivation and illness can exacerbate <i>SCN8A</i>-related seizures; thus, good sleep hygiene should be encouraged. Comorbidity with sleep apnea can also occur frequently in individuals with epilepsy [<a class="bk_pop" href="#scn8a-ee.REF.malow.2000.1002">Malow et al 2000</a>], and can influence seizure control, behavior, and cognition. Polysomnography should be considered if obstructive or central sleep apnea is suspected.</p><p><b>Caregivers.</b> For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div><div id="scn8a-ee.Surveillance"><h3>Surveillance</h3><p>Evaluate periodically for neurologic, cognitive, and/or behavioral deterioration.</p><p>Monitor with EEG and other modalities (e.g., video EEG telemetry or ambulatory EEG) when new or different seizure types are suspected.</p><p>Because of the increased risk of SUDEP, some families use oxygen monitoring during sleep.</p></div><div id="scn8a-ee.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Several families of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals report worsening of seizures with levetiracetam (Keppra<sup>&#x000ae;</sup>) [M Hammer, unpublished data].</p></div><div id="scn8a-ee.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#scn8a-ee.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="scn8a-ee.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="scn8a-ee.Genetic_Counseling"><h2 id="_scn8a-ee_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="scn8a-ee.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SCN8A</i>-related epilepsy with encephalopathy is expressed in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (i.e., <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> mutation of <i>SCN8A</i> results in the disorder).</p></div><div id="scn8a-ee.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most probands with <i>SCN8A</i>-related epilepsy with encephalopathy reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, the most likely explanation is a <i>de novo</i> pathogenic variant in the proband; another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Molecular genetic tests sensitive enough to detect low-level germline mosaicism, such as <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>-specific <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> or high-coverage <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> methods, should be considered.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents: if the <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but slightly greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>SCN8A</i>-related epilepsy with encephalopathy has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, individuals with <i>SCN8A</i>-related epilepsy with encephalopathy typically do not reproduce.</p><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents but appears to be low given that most probands with <i>SCN8A</i>-related epilepsy with encephalopathy reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="scn8a-ee.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul></div><div id="scn8a-ee.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Risk to future pregnancies is presumed to be low as the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> most likely has a <i>de novo SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, couples with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child may wish to consider prenatal testing or <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> in future pregnancies as the risk for <i>SCN8A</i>-related epilepsy with encephalopathy may be greater than in the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</p></div></div><div id="scn8a-ee.Resources"><h2 id="_scn8a-ee_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dravet Syndrome Foundation</b></div><div><b>Phone:</b> 203-392-1950</div><div><b>Fax:</b> 203-907-1940</div><div><b>Email:</b> info@dravetfoundation.org</div><div><a href="http://www.dravetfoundation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dravetfoundation.org</a></div></li><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Epilepsy Canada</b></div><div>Canada</div><div><b>Phone:</b> 877-734-0873</div><div><b>Email:</b> epilepsy@epilepsy.ca</div><div><a href="http://www.epilepsy.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.ca</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="scn8a-ee.Molecular_Genetics"><h2 id="_scn8a-ee_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="scn8a-ee.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SCN8A-Related Epilepsy with Encephalopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK379665/table/scn8a-ee.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scn8a-ee.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_scn8a-ee.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6334" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SCN8A</i></a></td><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6334" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q13<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UQD0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sodium channel protein type 8 subunit alpha</a></td><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/SCN8A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN8A @ LOVD</a></td><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SCN8A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN8A</a></td><td headers="hd_b_scn8a-ee.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SCN8A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SCN8A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="scn8a-ee.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="scn8a-ee.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SCN8A-Related Epilepsy with Encephalopathy (<a href="/omim/600702,614306,614558" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK379665/table/scn8a-ee.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scn8a-ee.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600702" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600702</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614306" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614306</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614558" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614558</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>SCN8A</i> comprises 27 exons. Exon 1 encodes the noncoding 5' UTR. The 26 protein-coding exons encode a protein of 1980 amino acids (<a href="/protein/NP_055006.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055006.1</a>). The approximate position of each <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> is indicated in <a class="figpopup" href="/books/NBK379665/figure/scn8a-ee.F1/?report=objectonly" target="object" rid-figpopup="figscn8aeeF1" rid-ob="figobscn8aeeF1">Figure 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figscn8aeeF1" co-legend-rid="figlgndscn8aeeF1"><a href="/books/NBK379665/figure/scn8a-ee.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figscn8aeeF1" rid-ob="figobscn8aeeF1"><img class="small-thumb" src="/books/NBK379665/bin/scn8a-ee-Image001.gif" src-large="/books/NBK379665/bin/scn8a-ee-Image001.jpg" alt="Figure 1. . Intron-exon organization of SCN8A." /></a><div class="icnblk_cntnt" id="figlgndscn8aeeF1"><h4 id="scn8a-ee.F1"><a href="/books/NBK379665/figure/scn8a-ee.F1/?report=objectonly" target="object" rid-ob="figobscn8aeeF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Intron-exon organization of <i>SCN8A</i>. Horizontal bars mark the positions of the introns of the sodium channel protein type 1.6 subunit alpha (Na<sub>v</sub>1.6) superimposed on the secondary structure of the sodium channel [Plummer et al 1998]. </p></div></div><p>It is important to recognize that the structure of <i>SCN8A</i> includes the alternatively spliced exons 6A (adult) and 6N (neonatal) that encode segment 3/4 of <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> I, as well as the alternatively spliced exons 21A (adult) and 21N (neonatal) that encode segment 3/4 of domain 3. Note: Exon 21N is a "poison" <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> that contains an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> stop codon and encodes a truncated protein terminating in domain 3 that does not have channel activity.</p><ul><li class="half_rhythm"><div>During the first year of postnatal life, the "neonatal" and the "adult" exons are expressed in roughly equal proportions [<a class="bk_pop" href="#scn8a-ee.REF.obrien.2012.18459">O'Brien et al 2012</a>].</div></li><li class="half_rhythm"><div>Exon 21N is expressed at a low level in non-neuronal cells including glia.</div></li></ul><p>The most complete full-length reference transcript contains <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6N and exon 21A: <a href="/nuccore/NM_014191.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014191.3</a> (<a href="http://uswest.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000196876;r=12:51590266-51812864;t=ENST00000354534" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000354534</a>).</p><p>Note that the reference sequence missing <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 21 should not be used for sequence comparisons: <a href="/nuccore/NM_001177984.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001177984.2</a> (<a href="http://www.ensembl.org/Homo_sapiens/Transcript/Summary?g=ENSG00000196876;r=12:51591236-51812864;t=ENST00000545061" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENST00000545061</a>).</p><p><b>Benign variants.</b> See <a class="figpopup" href="/books/NBK379665/table/scn8a-ee.T.scn8a_variants_discussed_in_t/?report=objectonly" target="object" rid-figpopup="figscn8aeeTscn8avariantsdiscussedint" rid-ob="figobscn8aeeTscn8avariantsdiscussedint">Table 2</a>.</p><p><b>Variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>.</b> A <i>SCN8A</i> 2-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> protein truncation variant was identified in a child with intellectual disability, pan cerebellar atrophy, and ataxia but no seizures [<a class="bk_pop" href="#scn8a-ee.REF.trudeau.2006.527">Trudeau et al 2006</a>]. It is unknown if the findings in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> result from the predicted loss of channel function resulting from this <i>SCN8A</i> variant or from an unrelated developmental disorder. Three additional <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> family members with the <i>SCN8A</i> variant had a history of cognitive impairment; however, the clinical information available for heterozygous relatives was incomplete.</p><p>An individual with intellectual disability, severe speech delay, absence seizures, and QRS-fragmentation on ECG had a rare <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> (<a href="/nuccore/NM_014191.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014191.3</a>:c.4748T&#x0003e;C, p.Ile1583Thr) inherited on the maternal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> along with a <i>de nov</i>o multiexon <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the paternal allele [<a class="bk_pop" href="#scn8a-ee.REF.berghuis.2015.141">Berghuis et al 2015</a>]. The deletion involving exons 2-14 was mosaic in the child and estimated to occur in 50% of peripheral blood cells. This case suggests that complex alterations in <i>SCN8A</i> may underlie at least some instances of epilepsy and cognitive impairment. Interestingly, this individual also had a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SCN5A</i> missense variant (<a href="/projects/SNP/snp_ref.cgi?searchType=adhoc_search&#x00026;type=rs&#x00026;rs=rs41313691" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs41313691</a>) of uncertain significance.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (c.4447G&#x0003e;A; p.Glu1483Lys) was found in six individuals with benign infantile seizures (afebrile focal or generalized tonic-clonic) and paroxysmal dyskinesia from three unrelated families [<a class="bk_pop" href="#scn8a-ee.REF.gardella.2016.428">Gardella et al 2016</a>]. The onset of clinical manifestations occurred during the first to second years of life. Some heterozygotes for the <i>SCN8A</i> variant were unaffected, implying reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Pathogenic variants.</b> The <i>SCN8A</i> pathogenic variants identified in the first 100 individuals with epileptic encephalopathy were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants with the exception of one <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant predicted to cause an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#scn8a-ee.REF.rauch.2012.1674">Rauch et al 2012</a>; <a class="bk_pop" href="#scn8a-ee.REF.veeramah.2012.502">Veeramah et al 2012</a>; <a class="bk_pop" href="#scn8a-ee.REF.allen.2013.217">Allen et al 2013</a>; <a class="bk_pop" href="#scn8a-ee.REF.carvill.2013.825">Carvill et al 2013</a>; <a class="bk_pop" href="#scn8a-ee.REF.de_kovel.2014.1511">de Kovel et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.estacion.2014.117">Estacion et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.ohba.2014.994">Ohba et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.vaher.2014.np202">Vaher et al 2014</a>; <a class="bk_pop" href="#scn8a-ee.REF.blanchard.2015.330">Blanchard et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.dyment.2015.34">Dyment et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.fung.2015.1319">Fung et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.kong.2015a.431">Kong et al 2015a</a>; <a class="bk_pop" href="#scn8a-ee.REF.larsen.2015.480">Larsen et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.mercimekmahmutoglu.2015.707">Mercimek-Mahmutoglu et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.olson.2015.2017">Olson et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.singh.2015.69">Singh et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.takahashi.2015.758">Takahashi et al 2015</a>; <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015a.114">Wagnon et al 2015a</a>; <a class="bk_pop" href="#scn8a-ee.REF.boerma.2016.192">Boerma et al 2016</a>; M Hammer, unpublished data]. All variants were <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, except two that were inherited from a parent mosaic for the variant.</p><p>Approximately one third of the 100 individuals with an <i>SCN8A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a recurrent pathogenic variant that has been observed in up to ten unrelated individuals [<a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015.104">Wagnon &#x00026; Meisler 2015</a>, <a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015a.114">Wagnon et al 2015a</a>]. Many of the recurrent pathogenic variants arise due to deamination of CpG dinucleotides, often in arginine codons. The locations of recurrent pathogenic variants are shown in <a class="figpopup" href="/books/NBK379665/figure/scn8a-ee.F2/?report=objectonly" target="object" rid-figpopup="figscn8aeeF2" rid-ob="figobscn8aeeF2">Figure 2</a> and several examples are listed in <a href="/books/NBK379665/bin/scn8a-ee-Table3.pdf">Table 3</a> (pdf).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figscn8aeeF2" co-legend-rid="figlgndscn8aeeF2"><a href="/books/NBK379665/figure/scn8a-ee.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figscn8aeeF2" rid-ob="figobscn8aeeF2"><img class="small-thumb" src="/books/NBK379665/bin/scn8a-ee-Image002.gif" src-large="/books/NBK379665/bin/scn8a-ee-Image002.jpg" alt="Figure 2. . Positions of SCN8A missense pathogenic variants in the sodium channel protein type 1." /></a><div class="icnblk_cntnt" id="figlgndscn8aeeF2"><h4 id="scn8a-ee.F2"><a href="/books/NBK379665/figure/scn8a-ee.F2/?report=objectonly" target="object" rid-ob="figobscn8aeeF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Positions of <i>SCN8A</i> missense pathogenic variants in the sodium channel protein type 1.6 subunit alpha (Na<sub>v</sub>1.6). The protein has four homologous domains (D1 to D4), each containing six transmembrane segments (S1-S6) [Wagnon &#x00026; Meisler 2015]. </p></div></div><p>The clinical variation among individuals with identical pathogenic variants may be as great as that among individuals with different pathogenic variants, indicating the important roles of background genetic and developmental variation on clinical outcome [<a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015.104">Wagnon &#x00026; Meisler 2015</a>]. The locations of known pathogenic variants in the Na<sub>v</sub>1.6 channel protein are indicated in <a class="figpopup" href="/books/NBK379665/figure/scn8a-ee.F2/?report=objectonly" target="object" rid-figpopup="figscn8aeeF2" rid-ob="figobscn8aeeF2">Figure 2</a>.</p><p>It is important to note that some <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants may not be pathogenic (e.g., <a class="bk_pop" href="#scn8a-ee.REF.blanchard.2015.330">Blanchard et al [2015]</a>).</p><div id="scn8a-ee.T.scn8a_variants_discussed_in_t" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SCN8A</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK379665/table/scn8a-ee.T.scn8a_variants_discussed_in_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scn8a-ee.T.scn8a_variants_discussed_in_t_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3979A&#x0003e;G</td><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile1327Val</td><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_014191.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014191<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_055006.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055006<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4447G&#x0003e;A</td><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu1483Lys</td></tr><tr><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4748T&#x0003e;C</td><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile1583Thr</td></tr><tr><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4850G&#x0003e;A</td><td headers="hd_h_scn8a-ee.T.scn8a_variants_discussed_in_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1617Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p>See <a href="/books/NBK379665/bin/scn8a-ee-Table3.pdf">Table 3</a> (pdf) for additional <i>SCN8A</i> variants.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SCN8A</i> encodes the sodium channel protein type 1.6 subunit alpha (isoform Na<sub>v</sub>1.6) that contains 1980 amino acids. The protein includes four homologous domains with six transmembrane segments each, as well as two large cytoplasmic loops, a short cytoplasmic inactivation gate, and cytoplasmic N-terminal and C-terminal domains (<a class="figpopup" href="/books/NBK379665/figure/scn8a-ee.F1/?report=objectonly" target="object" rid-figpopup="figscn8aeeF1" rid-ob="figobscn8aeeF1">Figure 1</a>, with <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> designations and functional domains marked). The amino acids forming the sodium- specific pore are located in segments S5 and S6 of each <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p>The protein is highly conserved through evolution, and the human sequence can be aligned with the bacterial sodium channel, whose crystal structure has been determined.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants result in substitution of a single amino acid. Of the nine pathogenic variants tested functionally, seven resulted in elevated channel activity due to premature channel opening or impaired channel closing. Elevated activity of Na<sub>v</sub>1.6 leads to neuronal hyperexcitability and seizures in a mouse model of <i>SCN8A</i>-related epilepsy with encephalopathy [<a class="bk_pop" href="#scn8a-ee.REF.wagnon.2015b.506">Wagnon et al 2015b</a>]. Na<sub>v</sub>1.6 is expressed at a low level in cardiac ventricular myocytes, and cardiac arrhythmia is seen in the mouse model, suggesting that sudden unexplained death in epilepsy (SUDEP) may have a cardiac component [<a class="bk_pop" href="#scn8a-ee.REF.frasier.2016.12838">Frasier et al 2016</a>].</p></div><div id="scn8a-ee.References"><h2 id="_scn8a-ee_References_">References</h2><div id="scn8a-ee.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.allen.2013.217">Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">501</span>:217–21.</span> [<a href="/pmc/articles/PMC3773011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773011</span></a>] [<a href="/pubmed/23934111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23934111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.berghuis.2015.141">Berghuis B, de Kovel CG, van Iterson L, Lamberts RJ, Sander JW, Lindhout D, Koeleman BP. Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy. <span><span class="ref-journal">Epilepsy Res. </span>2015;<span class="ref-vol">115</span>:141–4.</span> [<a href="/pubmed/26220391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26220391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.blanchard.2015.330">Blanchard MG, Willemsen MH, Walker JB, Dib-Hajj SD, Waxman SG, Jongmans MC, Kleefstra T, van de Warrenburg BP, Praamstra P, Nicolai J, Yntema HG, Bindels RJ, Meisler MH, Kamsteeg EJ. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:330–7.</span> [<a href="/pmc/articles/PMC4413743/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4413743</span></a>] [<a href="/pubmed/25725044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25725044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.boerma.2016.192">Boerma RS, Braun KP, van de Broek MP, van Berkestijn FM, Swinkels ME, Hagebeuk EO, Lindhout D, van Kempen M, Boon M, Nicolai J, de Kovel CG, Brilstra EH, Koeleman BP. Remarkable phenytoin sensitivity in 4 children with SCN8A-related epilepsy: a molecular neuropharmacological approach. <span><span class="ref-journal">Neurotherapeutics. </span>2016;<span class="ref-vol">13</span>:192–7.</span> [<a href="/pmc/articles/PMC4720675/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4720675</span></a>] [<a href="/pubmed/26252990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26252990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.carvill.2013.825">Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, Moller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:825–30.</span> [<a href="/pmc/articles/PMC3704157/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3704157</span></a>] [<a href="/pubmed/23708187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23708187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.chipaux.2010.190">Chipaux M, Villeneuve N, Sabouraud P, Desguerre I, Boddaert N, Depienne C, Chiron C, Dulac O, Nabbout R. Unusual consequences of status epilepticus in Dravet syndrome. <span><span class="ref-journal">Seizure. </span>2010;<span class="ref-vol">19</span>:190–4.</span> [<a href="/pubmed/20172746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20172746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.de_kovel.2014.1511">de Kovel CG, Meisler MH, Brilstra EH, van Berkestijn FM, van 't Slot R, van Lieshout S, Nijman IJ, O'Brien JE, Hammer MF, Estacion M, Waxman SG, Dib-Hajj SD, Koeleman BP. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. <span><span class="ref-journal">Epilepsy Res. </span>2014;<span class="ref-vol">108</span>:1511–8.</span> [<a href="/pmc/articles/PMC4490185/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4490185</span></a>] [<a href="/pubmed/25239001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25239001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.dyment.2015.34">Dyment DA, Tetreault M, Beaulieu CL, Hartley T, Ferreira P, Chardon JW, Marcadier J, Sawyer SL, Mosca SJ, Innes AM, Parboosingh JS, Bulman DE, Schwartzentruber J, Majewski J, Tarnopolsky M, Boycott KM, Consortium FC. Care4Rare C. Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study. <span><span class="ref-journal">Clin Genet. </span>2015;<span class="ref-vol">88</span>:34–40.</span> [<a href="/pubmed/25046240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25046240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.estacion.2014.117">Estacion M, O'Brien JE, Conravey A, Hammer MF, Waxman SG, Dib-Hajj SD, Meisler MH. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy. <span><span class="ref-journal">Neurobiol Dis. </span>2014;<span class="ref-vol">69</span>:117–23.</span> [<a href="/pmc/articles/PMC4124819/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4124819</span></a>] [<a href="/pubmed/24874546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24874546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.fitzgerald.2015.223">Fitzgerald T, Gerety S, Jones W, van Kogelenberg M, King D, McRae J, Morley K, Parthiban V, Al-Turki S, Ambridge K, Barrett D, Bayzetinova T, Clayton S, Coomber E, Gribble S, Jones P, Krishnappa N, Mason L, Middleton A, Miller R, Prigmore E, Rajan D, Sifrim A, Tivey A, Ahmed M, Akawi N, Andrews R, Anjum U, Archer H, Armstrong R, Balasubramanian M, Banerjee R, Baralle D, Batstone P, Baty D, Bennett C, Berg J, Bernhard B, Bevan A, Blair E, Blyth M, Bohanna D, Bourdon L, Bourn D, Brady A, Bragin E, Brewer C, Brueton L, Brunstrom K, Bumpstead S, Bunyan D, Burn J, Burton J, Canham N, Castle B, Chandler K, Clasper S, Clayton-Smith J, Cole T, Collins A, Collinson M, Connell F, Cooper N, Cox H, Cresswell L, Cross G, Crow Y, D&#x02019;Alessandro M, Dabir T, Davidson R, Davies S, Dean J, Deshpande C, Devlin G, Dixit A, Dominiczak A, Donnelly C, Donnelly D, Douglas A, Duncan A, Eason J, Edkins S, Ellard S, Ellis P, Elmslie F, Evans K, Everest S, Fendick T, Fisher R, Flinter F, Foulds N, Fryer A, Fu B, Gardiner C, Gaunt L, Ghali N, Gibbons R, Gomes Pereira S, Goodship J, Goudie D, Gray E, Greene P, Greenhalgh L, Harrison L, Hawkins R, Hellens S, Henderson A, Hobson E, Holden S, Holder S, Hollingsworth G, Homfray T, Humphreys M, Hurst J, Ingram S, Irving M, Jarvis J, Jenkins L, Johnson D, Jones D, Jones E, Josifova D, Joss S, Kaemba B, Kazembe S, Kerr B, Kini U, Kinning E, Kirby G, Kirk C, Kivuva E, Kraus A, Kumar D, Lachlan K, Lam W, Lampe A, Langman C, Lees M, Lim D, Lowther G, Lynch S, Magee A, Maher E, Mansour S, Marks K, Martin K, Maye U, McCann E, McConnell V, McEntagart M, McGowan R, McKay K, McKee S, McMullan D, McNerlan S, Mehta S, Metcalfe K, Miles E, Mohammed S, Montgomery T, Moore D, Morgan S, Morris A, Morton J, Mugalaasi H, Murday V, Nevitt L, Newbury-Ecob R, Norman A, O'Shea R, Ogilvie C, Park S, Parker M, Patel C, Paterson J, Payne S, Phipps J, Pilz D, Porteous D, Pratt N, Prescott K, Price S, Pridham A, Procter A, Purnell H, Ragge N, Rankin J, Raymond L, Rice D, Robert L, Roberts E, Roberts G, Roberts J, Roberts P, Ross A, Rosser E, Saggar A, Samant S, Sandford R, Sarkar A, Schweiger S, Scott C, Scott R, Selby A, Seller A, Sequeira C, Shannon N, Sharif S, Shaw-Smith C, Shearing E, Shears D, Simonic I, Simpkin D, Singzon R, Skitt Z, Smith A, Smith B, Smith K, Smithson S, Sneddon L, Splitt M, Squires M, Stewart F, Stewart H, Suri M, Sutton V, Swaminathan G, Sweeney E, Tatton-Brown K, Taylor C, Taylor R, Tein M, Temple I, Thomson J, Tolmie J, Torokwa A, Treacy B, Turner C, Turnpenny P, Tysoe C, Vandersteen A, Vasudevan P, Vogt J, Wakeling E, Walker D, Waters J, Weber A, Wellesley D, Whiteford M, Widaa S, Wilcox S, Williams D, Williams N, Woods G, Wragg C, Wright M, Yang F, Yau M, Carter N, Parker M, Firth H, FitzPatrick D, Wright C, Barrett J, Hurles M. Large-scale discovery of novel genetic causes of developmental disorders. <span><span class="ref-journal">Nature. </span>2015;<span class="ref-vol">519</span>:223–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.frasier.2016.12838">Frasier CR, Wagnon JL, Bao YO, McVeigh LG, Lopez-Santiago LF, Meisler MH, Isom LL. Cardiac arrhythmia in a mouse model of sodium channel SCN8A epileptic encephalopathy. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2016;<span class="ref-vol">113</span>:12838–43.</span> [<a href="/pmc/articles/PMC5111690/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5111690</span></a>] [<a href="/pubmed/27791149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27791149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.fung.2015.1319">Fung LW, Kwok SL, Tsui KW. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:1319–20.</span> [<a href="/pubmed/26235738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26235738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.gardella.2016.428">Gardella E, Becker F, M&#x000f8;ller RS, Schubert J, Lemke JR, Larsen LH, Eiberg H, Nothnagel M, Thiele H, Altm&#x000fc;ller J, Syrbe S, Merkenschlager A, Bast T, Steinhoff B, N&#x000fc;rnberg P, Mang Y, Bakke M&#x000f8;ller L, Gellert P, Heron SE, Dibbens LM, Weckhuysen S, Dahl HA, Biskup S, Tommerup N, Hjalgrim H, Lerche H, Beniczky S, Weber YG. Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation. <span><span class="ref-journal">Ann Neurol. </span>2016;<span class="ref-vol">79</span>:428–36.</span> [<a href="/pubmed/26677014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26677014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.kong.2015a.431">Kong W, Zhang Y, Gao Y, Liu X, Gao K, Xie H, Wang J, Wu Y, Zhang Y, Wu X, Jiang Y. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. <span><span class="ref-journal">Epilepsia. </span>2015a;<span class="ref-vol">56</span>:431–8.</span> [<a href="/pubmed/25785782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25785782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.kong.2015b.1320">Kong W, Zhang Y, Jiang Y. In response: SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. <span><span class="ref-journal">Epilepsia. </span>2015b;<span class="ref-vol">56</span>:1320.</span> [<a href="/pubmed/26235739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26235739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.larsen.2015.480">Larsen J, Carvill GL, Gardella E, Kluger G, Schmiedel G, Barisic N, Depienne C, Brilstra E, Mang Y, Nielsen JE, Kirkpatrick M, Goudie D, Goldman R, Jahn JA, Jepsen B, Gill D, Docker M, Biskup S, McMahon JM, Koeleman B, Harris M, Braun K, de Kovel CG, Marini C, Specchio N, Djemie T, Weckhuysen S, Tommerup N, Troncoso M, Troncoso L, Bevot A, Wolff M, Hjalgrim H, Guerrini R, Scheffer IE, Mefford HC, Moller RS, Euro ERESCCRP. The phenotypic spectrum of SCN8A encephalopathy. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:480–9.</span> [<a href="/pmc/articles/PMC4336074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4336074</span></a>] [<a href="/pubmed/25568300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25568300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.malow.2000.1002">Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">55</span>:1002–7.</span> [<a href="/pubmed/11061259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11061259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.marini.2011.24">Marini C, Scheffer IE, Nabbout R, Suls A, De Jonghe P, Zara F, Guerrini R. The genetics of Dravet syndrome. <span><span class="ref-journal">Epilepsia. </span>2011;<span class="ref-vol">52</span> Suppl 2:24–9.</span> [<a href="/pubmed/21463275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21463275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.mercimekmahmutoglu.2015.707">Mercimek-Mahmutoglu S, Patel J, Cordeiro D, Hewson S, Callen D, Donner EJ, Hahn CD, Kannu P, Kobayashi J, Minassian BA, Moharir M, Siriwardena K, Weiss SK, Weksberg R, Snead OC 3rd. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:707–16.</span> [<a href="/pubmed/25818041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25818041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.obrien.2012.18459">O'Brien JE, Sharkey LM, Vallianatos CN, Han C, Blossom JC, Yu T, Waxman SG, Dib-Hajj SD, Meisler MH. Interaction of voltage-gated sodium channel Nav1.6 (SCN8A) with microtubule-associated protein Map1b. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:18459–66.</span> [<a href="/pmc/articles/PMC3365756/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3365756</span></a>] [<a href="/pubmed/22474336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22474336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.ohba.2014.994">Ohba C, Kato M, Takahashi S, Lerman-Sagie T, Lev D, Terashima H, Kubota M, Kawawaki H, Matsufuji M, Kojima Y, Tateno A, Goldberg-Stern H, Straussberg R, Marom D, Leshinsky-Silver E, Nakashima M, Nishiyama K, Tsurusaki Y, Miyake N, Tanaka F, Matsumoto N, Saitsu H. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:994–1000.</span> [<a href="/pubmed/24888894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24888894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.olson.2015.2017">Olson HE, Tambunan D, LaCoursiere C, Goldenberg M, Pinsky R, Martin E, Ho E, Khwaja O, Kaufmann WE, Poduri A. Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2017–25.</span> [<a href="/pmc/articles/PMC5722031/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5722031</span></a>] [<a href="/pubmed/25914188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25914188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.plummer.1998.287">Plummer NW, Galt J, Jones JM, Burgess DL, Sprunger LK, Kohrman DC, Meisler MH. Exon organization, coding sequence, physical mapping, and polymorphic intragenic markers for the human neuronal sodium channel gene SCN8A. <span><span class="ref-journal">Genomics. </span>1998;<span class="ref-vol">54</span>:287–96.</span> [<a href="/pubmed/9828131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9828131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.rauch.2012.1674">Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. <span><span class="ref-journal">Lancet. </span>2012;<span class="ref-vol">380</span>:1674–82.</span> [<a href="/pubmed/23020937" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23020937</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.selmer.2009.555">Selmer KK, Lund C, Brandal K, Undlien DE, Brodtkorb E. SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features. <span><span class="ref-journal">Epilepsy Behav. </span>2009;<span class="ref-vol">16</span>:555–7.</span> [<a href="/pubmed/19782004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19782004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.singh.2015.69">Singh R, Jayapal S, Goyal S, Jungbluth H, Lascelles K. Early-onset movement disorder and epileptic encephalopathy due to de novo dominant SCN8A mutation. <span><span class="ref-journal">Seizure. </span>2015;<span class="ref-vol">26</span>:69–71.</span> [<a href="/pubmed/25799905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25799905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.takahashi.2015.758">Takahashi S, Yamamoto S, Okayama A, Araki A, Saitsu H, Matsumoto N, Azuma H. Electroclinical features of epileptic encephalopathy caused by SCN8A mutation. <span><span class="ref-journal">Pediatr Int. </span>2015;<span class="ref-vol">57</span>:758–62.</span> [<a href="/pubmed/25951352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25951352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.takayanagi.2010.1886">Takayanagi M, Haginoya K, Umehara N, Kitamura T, Numata Y, Wakusawa K, Hino-Fukuyo N, Mazaki E, Yamakawa K, Ohura T, Ohtake M. Acute encephalopathy with a truncation mutation in the SCN1A gene: a case report. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:1886–8.</span> [<a href="/pubmed/20491869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20491869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.trudeau.2006.527">Trudeau MM, Dalton JC, Day JW, Ranum LP, Meisler MH. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:527–30.</span> [<a href="/pmc/articles/PMC2564538/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564538</span></a>] [<a href="/pubmed/16236810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16236810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.vaher.2014.np202">Vaher U, Noukas M, Nikopensius T, Kals M, Annilo T, Nelis M, Ounap K, Reimand T, Talvik I, Ilves P, Piirsoo A, Seppet E, Metspalu A, Talvik T. De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders. <span><span class="ref-journal">J Child Neurol. </span>2014;<span class="ref-vol">29</span>:NP202–6.</span> [<a href="/pubmed/24352161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24352161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.veeramah.2012.502">Veeramah KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG, Talwar D, Girirajan S, Eichler EE, Restifo LL, Erickson RP, Hammer MF. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:502–10.</span> [<a href="/pmc/articles/PMC3309181/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3309181</span></a>] [<a href="/pubmed/22365152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22365152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.wagnon.2015a.114">Wagnon JL, Barker BS, Hounshell JA, Haaxma CA, Shealy A, Moss T, Parikh S, Messer RD, Patel MK, Meisler MH. Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2015a;<span class="ref-vol">3</span>:114–23.</span> [<a href="/pmc/articles/PMC4748308/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4748308</span></a>] [<a href="/pubmed/26900580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26900580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.wagnon.2015b.506">Wagnon JL, Korn MJ, Parent R, Tarpey TA, Jones JM, Hammer MF, Murphy GG, Parent JM, Meisler MH. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy. <span><span class="ref-journal">Hum Mol Genet. </span>2015b;<span class="ref-vol">24</span>:506–15.</span> [<a href="/pmc/articles/PMC4275076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4275076</span></a>] [<a href="/pubmed/25227913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25227913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scn8a-ee.REF.wagnon.2015.104">Wagnon JL, Meisler MH. Recurrent and non-recurrent mutations of SCN8A in epileptic encephalopathy. <span><span class="ref-journal">Front Neurol. </span>2015;<span class="ref-vol">6</span>:104.</span> [<a href="/pmc/articles/PMC4432670/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4432670</span></a>] [<a href="/pubmed/26029160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26029160</span></a>]</div></li></ul></div></div><div id="scn8a-ee.Chapter_Notes"><h2 id="_scn8a-ee_Chapter_Notes_">Chapter Notes</h2><div id="scn8a-ee.Author_Notes"><h3>Author Notes</h3><p>The Meisler laboratory carried out the first studies of <i>SCN8A</i> structure and expression and currently studies the function of pathogenic alleles in mouse models and transfected cells.</p><p>The Hammer lab identified the first case of SCN8A epilepsy and is establishing a registry and an online database of the clinical features of patients with pathogenic variants in <i>SCN8A</i> (<a href="http://www.SCN8A.net" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.SCN8A.net</a>). The Hammer and Meisler labs are collaborating on experiments using mouse models of SCN8A epilepsy.</p></div><div id="scn8a-ee.Acknowledgments"><h3>Acknowledgments</h3><p>We thank Wishes for Elliott (<a href="http://www.wishesforelliott.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.wishesforelliott.org</a>) for funding the first <i>SCN8A</i> workshop in association with the American Epilepsy Society conference in Washington DC (April 20, 2015) and for initiating the process to make this <i>GeneReview</i> possible.</p></div><div id="scn8a-ee.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 August 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>29 September 2015 (mfh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK379665</span><span class="label">PMID: <a href="/pubmed/27559564" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27559564</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gefs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/etha/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK379665&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK379665/?report=reader">PubReader</a></li><li><a href="/books/NBK379665/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK379665" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK379665" style="display:none" title="Cite this Page"><div class="bk_tt">Hammer MF, Wagnon JL, Mefford HC, et al. SCN8A-Related Epilepsy with Encephalopathy. 2016 Aug 25. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK379665/pdf/Bookshelf_NBK379665.pdf">PDF version of this page</a> (579K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#scn8a-ee.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#scn8a-ee.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#scn8a-ee.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#scn8a-ee.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#scn8a-ee.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#scn8a-ee.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#scn8a-ee.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#scn8a-ee.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#scn8a-ee.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#scn8a-ee.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#scn8a-ee.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6334[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SCN8A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4309392" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4309392" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4309392" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4309392" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27905812" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Khaikin Y, Mercimek-Mahmutoglu S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28923014" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.</a><span class="source">[BMC Med Genet. 2017]</span><div class="brieflinkpop offscreen_noflow">SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang J, Gao H, Bao X, Zhang Q, Li J, Wei L, Wu X, Chen Y, Yu S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2017 Sep 18; 18(1):104. Epub 2017 Sep 18.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27559564" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27559564" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0415eedde08911690a40c3">SCN8A-Related Epilepsy with Encephalopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SCN8A-Related Epilepsy with Encephalopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:07:42-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A2B8CE040763100000000061F0231&amp;ncbi_session=CE8A2B8CE0415ED1_1567SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK379665%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK379665&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK379665/&amp;ncbi_pagename=SCN8A-Related Epilepsy with Encephalopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A2B8CE0415ED1_1567SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>